By Representatives Ehrlich of Marblehead and Decker of Cambridge, a petition (accompanied by bill, House, No. 3319) of Lori A. Ehrlich and others relative to eligibility for earned income tax credits. Revenue.
By Mr. McGee, a petition (accompanied by bill, Senate, No. 1950) of Thomas M. McGee, Jonathan Hecht and Sal N. DiDomenico for legislation relative to vehicle idling. Transportation.
By Ms. Lovely, a petition (accompanied by bill, Senate, No. 1023) of Joan B. Lovely, Michelle M. DuBois, Eric P. Lesser, Jack Lewis and other members of the General Court for legislation to establish the Massachusetts pregnant workers fairness act. Labor and Workforce Development.
By Mr. Rogers of Cambridge, a petition (accompanied by bill, House, No. 1038) of David M. Rogers and others relative to protecting pregnant workers from discrimination in the workplace. Labor and Workforce Development.
By Mr. DiDomenico, a petition (accompanied by bill) (subject to Joint Rule 12) of Sal N. DiDomenico and Daniel J. Ryan for legislation to establish a sick leave bank for Ramona Foster, an employee of the Department of Elementary and Secondary Education. Public Service.
Maddy summaryThis bill amends existing healthcare regulations to include continuous glucose monitoring systems and related diabetes supplies within the state's drug selection and coverage program. It defines these systems as devices that continuously sense and display blood glucose levels and explicitly lists components like sensors, transmitters, and delivery devices as eligible for selection. Under the new rules, the state commission must choose one generic and one brand-name version of these monitoring systems, just as it does for traditional medications. Once selected, these systems and their necessary parts would be covered without deductibles or co-insurance, and co-payments for brand-name options would be capped at $25 per 30-day supply. The legislation also expands the list of covered diabetes supplies to include items such as syringes, needles, and calibration strips, ensuring they are exempt from cost-sharing requirements.
